Erkan Alataş
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Erkan Alataş has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Sevgi Özkan
Pamukkale University
3 shared publications - Pınar Serçekuş
Pamukkale University
2 shared publications - Sinem Göral Türkcü
Pamukkale Universitesi
2 shared publications - Soner Gök
Pamukkale Universitesi
2 shared publications - Yeliz Arman Karakaya
Pamukkale Universitesi
2 shared publications - Ömer Tolga Güler
Department of Gynecology and Obstetrics, Faculty of Medicine, Pamukkale University, Denizli, Turkey
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Izmir Katip Celebi University Faculty of Health Sciences in İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 11 (3) , 549-555
Attitudes of Health Professional Parents Towards Childhood Vaccination
Objective: Attitudes of health professionals towards vaccines can affect the attitudes of society towards vaccination. Therefore, they play a crucial role in the success of immunisation programmes. This study aimed to assess the attitudes of health professional parents towards childhood vaccines. Material and Methods: A cross-sectional survey design was used in the study. The sample included 169 health professionals. Data were collected online using an Introductory Information Form and the Parent Attitudes about Childhood Vaccines (PACV) Questionnaire, which was created by the researchers. Results: Our study, vaccine hesitancy regarding childhood immunisations was determined as 10.7% among health professional parents. Among these professionals, 16% reported hesitancy towards vaccines in general while 1.8% expressed opposition to vaccination. The primary reason for vaccine hesitancy was a lack of confidence. Vaccine hesitancy was found to be high among health professionals who were high school graduates and those with low economic status. Conversely, it was found to be low among those who used scientific publications as a source of information, held at least a master’s degree, and had a high economic status. Conclusion: Directing health professionals to accurate sources of information on vaccines can reduce vaccine hesitancy, especially among people with low education levels. It is thought that confidence problems, which are the primary cause of vaccine hesitancy, can be alleviated by providing reliable information about vaccine production technologies and contents
- 30 September 2026
- Published by Izmir Katip Celebi University Faculty of Health Sciences in İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi
- Vol. 11 (3) , 549-555
Open AccessAttitudes of Health Professional Parents Towards Childhood Vaccination
Objective: Attitudes of health professionals towards vaccines can affect the attitudes of society towards vaccination. Therefore, they play a crucial role in the success of immunisation programmes. This study aimed to assess the attitudes of health professional parents towards childhood vaccines. Material and Methods: A cross-sectional survey design was used in the study. The sample included 169 health professionals. Data were collected online using an Introductory Information Form and the Parent Attitudes about Childhood Vaccines (PACV) Questionnaire, which was created by the researchers. Results: Our study, vaccine hesitancy regarding childhood immunisations was determined as 10.7% among health professional parents. Among these professionals, 16% reported hesitancy towards vaccines in general while 1.8% expressed opposition to vaccination. The primary reason for vaccine hesitancy was a lack of confidence. Vaccine hesitancy was found to be high among health professionals who were high school graduates and those with low economic status. Conversely, it was found to be low among those who used scientific publications as a source of information, held at least a master’s degree, and had a high economic status. Conclusion: Directing health professionals to accurate sources of information on vaccines can reduce vaccine hesitancy, especially among people with low education levels. It is thought that confidence problems, which are the primary cause of vaccine hesitancy, can be alleviated by providing reliable information about vaccine production technologies and contents
- Open Access
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 659-663
A rare case of ovarian pathology: diffuse large B cell lymphoma of over
Primary ovarian non-Hodgkin lymphoma is a challenging diagnosis due to its rarity, often leading to delayed treatment, wrong diagnosis, and inappropriate therapy. The patient in this case presentation presented with abdominal pain as the initial symptom. Subsequent abdominal computed tomography revealed a bilateral heterogeneous ovarian mass measuring approximately 6x10x10 cm on the left side and 14x10x7 cm on the right side. An intestinal mass lesion was observed in the ileal ans, causing diffuse wall thickening of ~2 cm at its widest point and focal lumen widening in an ~11 cm segment (lymphoma?). A transvaginal ultrasound was also performed, revealing two cystic masses, one measuring 10 cm and the other 12 cm, with dense and heterogeneous contents filling the uterine cavity and pelvis. Subsequently, a total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymph node dissection, and small bowel resection and anastomosis were performed.
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 659-663
Open AccessA rare case of ovarian pathology: diffuse large B cell lymphoma of over
Primary ovarian non-Hodgkin lymphoma is a challenging diagnosis due to its rarity, often leading to delayed treatment, wrong diagnosis, and inappropriate therapy. The patient in this case presentation presented with abdominal pain as the initial symptom. Subsequent abdominal computed tomography revealed a bilateral heterogeneous ovarian mass measuring approximately 6x10x10 cm on the left side and 14x10x7 cm on the right side. An intestinal mass lesion was observed in the ileal ans, causing diffuse wall thickening of ~2 cm at its widest point and focal lumen widening in an ~11 cm segment (lymphoma?). A transvaginal ultrasound was also performed, revealing two cystic masses, one measuring 10 cm and the other 12 cm, with dense and heterogeneous contents filling the uterine cavity and pelvis. Subsequently, a total abdominal hysterectomy, bilateral salpingo-oophorectomy, bilateral pelvic lymph node dissection, and small bowel resection and anastomosis were performed.
- Open Access
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 653-658
An unusual case report: retroperitoneal hydropic leiomyoma
Leiomyomas are one of the most prevalent gynecological conditions that cause bleeding in women, particularly in the postmenopausal and perimenopausal stages. Nonetheless, one of the rarest forms of myoma is retroperitoneal hydropic myoma. A 45-year-old woman with a history of four pregnancies, two cesarean sections, one vaginal delivery, and one abortion will be the subject of this case presentation. During her preoperative examination, a retroperitoneal hydropic myoma was discovered to be an adnexal mass. The patient's preoperative pelvic MRI was interpreted as follows: Approximately 15 x 16 cm in size, a giant cystic mass lesion filled the pelvis completely and extended superiorly to the umbilical level. It contained contrast-enhancing septal components, and in the superior left half, there was a contrast-enhancing and diffusion-restricting solid component that measured about 4 x 3 cm and was believed to be from the right ovary (mucinous ovarian carcinoma?). The uterus is being forced anteriorly by the giant mass lesion that has been described. A retroperitoneal cystic tumor was removed during the procedure. A hydropic leiomyoma without necrosis or hemorrhage was discovered by microscopic and histopathologic analysis. The hydropic degeneration of the leiomyoma and its uncommon location make this case remarkable. Furthermore, it was difficult to make an accurate diagnosis because it initially resembled an ovarian cyst.
- 10 July 2026
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 19 (3) , 653-658
Open AccessAn unusual case report: retroperitoneal hydropic leiomyoma
Leiomyomas are one of the most prevalent gynecological conditions that cause bleeding in women, particularly in the postmenopausal and perimenopausal stages. Nonetheless, one of the rarest forms of myoma is retroperitoneal hydropic myoma. A 45-year-old woman with a history of four pregnancies, two cesarean sections, one vaginal delivery, and one abortion will be the subject of this case presentation. During her preoperative examination, a retroperitoneal hydropic myoma was discovered to be an adnexal mass. The patient's preoperative pelvic MRI was interpreted as follows: Approximately 15 x 16 cm in size, a giant cystic mass lesion filled the pelvis completely and extended superiorly to the umbilical level. It contained contrast-enhancing septal components, and in the superior left half, there was a contrast-enhancing and diffusion-restricting solid component that measured about 4 x 3 cm and was believed to be from the right ovary (mucinous ovarian carcinoma?). The uterus is being forced anteriorly by the giant mass lesion that has been described. A retroperitoneal cystic tumor was removed during the procedure. A hydropic leiomyoma without necrosis or hemorrhage was discovered by microscopic and histopathologic analysis. The hydropic degeneration of the leiomyoma and its uncommon location make this case remarkable. Furthermore, it was difficult to make an accurate diagnosis because it initially resembled an ovarian cyst.
- Open Access
- 25 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Evaluation of serum calprotectin levels in patients with polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. PCOS is associated with many chronic complications such as endometrial thickening, endometrial cancer, breast cancer, infertility, dyslipidemia, and long-term cardiovascular disease. Therefore, many parameters and markers should be used in the evaluation of patients diagnosed with PCOS. Calprotectin has also been shown to be an important marker of destruction in many diseases that progress with inflammatory processes. The objective of our study was to examine the diagnostic efficacy of calprotectin in the context of polycystic ovary syndrome. In this study, 39 patients diagnosed with polycystic ovary syndrome and 41 healthy controls were analyzed. Serum calprotectin levels were compared between patients with different phenotypes of PCOS and a control group. Our study demonstrates significant differences in hormonal and inflammatory parameters between PCOS patients and healthy controls. PCOS patients exhibited significantly lower FSH levels and higher LH levels, resulting in a marked increase in the LH/FSH ratio. Additionally, DHEA-S and total testosterone levels were significantly elevated in the PCOS group, while SHBG levels were notably lower. The free androgen index (FAI) and serum calprotectin levels were also significantly higher in the PCOS group, highlighting the potential role of calprotectin in the pathophysiology of the disorder. Our study demonstrated that serum calprotectin levels are significantly higher in patients with PCOS compared to healthy controls. This finding underscores the potential role of calprotectin in the pathophysiology of PCOS and suggests that this marker could provide valuable insights into the inflammatory processes associated with the condition. However, further large-scale and long-term studies are necessary to better understand the impact of calprotectin on different PCOS phenotypes and its potential application in clinical practice.
- 25 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-6
Open AccessEvaluation of serum calprotectin levels in patients with polycystic ovary syndrome
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. PCOS is associated with many chronic complications such as endometrial thickening, endometrial cancer, breast cancer, infertility, dyslipidemia, and long-term cardiovascular disease. Therefore, many parameters and markers should be used in the evaluation of patients diagnosed with PCOS. Calprotectin has also been shown to be an important marker of destruction in many diseases that progress with inflammatory processes. The objective of our study was to examine the diagnostic efficacy of calprotectin in the context of polycystic ovary syndrome. In this study, 39 patients diagnosed with polycystic ovary syndrome and 41 healthy controls were analyzed. Serum calprotectin levels were compared between patients with different phenotypes of PCOS and a control group. Our study demonstrates significant differences in hormonal and inflammatory parameters between PCOS patients and healthy controls. PCOS patients exhibited significantly lower FSH levels and higher LH levels, resulting in a marked increase in the LH/FSH ratio. Additionally, DHEA-S and total testosterone levels were significantly elevated in the PCOS group, while SHBG levels were notably lower. The free androgen index (FAI) and serum calprotectin levels were also significantly higher in the PCOS group, highlighting the potential role of calprotectin in the pathophysiology of the disorder. Our study demonstrated that serum calprotectin levels are significantly higher in patients with PCOS compared to healthy controls. This finding underscores the potential role of calprotectin in the pathophysiology of PCOS and suggests that this marker could provide valuable insights into the inflammatory processes associated with the condition. However, further large-scale and long-term studies are necessary to better understand the impact of calprotectin on different PCOS phenotypes and its potential application in clinical practice.
- Open Access
- 16 July 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (1) , 8
Evaluation of Knowledge and Attitudes of Female University Students about Ovarian Reserve Awareness and Technologies for Ovarian Reserve: A Cross-Sectional Study
Purpose: The aim of this study was to evaluate the knowledge and attitudes of female university students about ovarian reserve awareness and technologies for ovarian reserve. Materials and methods: This study was designed as a descriptive and cross-sectional study and was conducted on 660 female university students. The data were collected by using a questionnaire form based on the literature on ovarian reserve and related technologies. The mean, standard deviation and percentage distributions of the data obtained through the WEB page and face-to-face interview technique were analysed in the SPSS programme. Results: 86.2% of the students wanted to have children in the future and 75.8% planned to have children between the ages of 26-30. 56.7% of the students were aware of the availability of tests related to ovarian reserve and 86.6% of them demanded the development of new tests. In case of low ovarian reserve, 65.6% of the students stated that they could have children earlier, 68% could freeze their eggs, 51.2% could freeze their embryos, 73.8% could adopt a child and 84.7% could continue their work/education. Conclusion: It is remarkable that the majority of the students did not make any attempt for ovarian reserve evaluation although they wanted to have a child. Among the reasons for this situation, besides the fact that the students are still receiving education, they have false beliefs that their ovarian reserves will be sufficient at the age when they want to have children, that a healthy lifestyle and activity protect the ovarian reserve, and that they can have children with assisted reproductive techniques even if their ovarian reserves are low. It is important to evaluate the ovarian reserves of young women at an early stage in order for them to make a more conscious career and family planning.
- 16 July 2024
- Published by Pamukkale University in Pamukkale Medical Journal
- Vol. 18 (1) , 8
Open AccessEvaluation of Knowledge and Attitudes of Female University Students about Ovarian Reserve Awareness and Technologies for Ovarian Reserve: A Cross-Sectional Study
Purpose: The aim of this study was to evaluate the knowledge and attitudes of female university students about ovarian reserve awareness and technologies for ovarian reserve. Materials and methods: This study was designed as a descriptive and cross-sectional study and was conducted on 660 female university students. The data were collected by using a questionnaire form based on the literature on ovarian reserve and related technologies. The mean, standard deviation and percentage distributions of the data obtained through the WEB page and face-to-face interview technique were analysed in the SPSS programme. Results: 86.2% of the students wanted to have children in the future and 75.8% planned to have children between the ages of 26-30. 56.7% of the students were aware of the availability of tests related to ovarian reserve and 86.6% of them demanded the development of new tests. In case of low ovarian reserve, 65.6% of the students stated that they could have children earlier, 68% could freeze their eggs, 51.2% could freeze their embryos, 73.8% could adopt a child and 84.7% could continue their work/education. Conclusion: It is remarkable that the majority of the students did not make any attempt for ovarian reserve evaluation although they wanted to have a child. Among the reasons for this situation, besides the fact that the students are still receiving education, they have false beliefs that their ovarian reserves will be sufficient at the age when they want to have children, that a healthy lifestyle and activity protect the ovarian reserve, and that they can have children with assisted reproductive techniques even if their ovarian reserves are low. It is important to evaluate the ovarian reserves of young women at an early stage in order for them to make a more conscious career and family planning.
- Open Access
Effects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
Background and Objectives: The goal of this study was to investigate the effect of selective serotonin reuptake inhibitor treatment on the ovarian reserves of women of reproductive age with major depressive disorder. Materials and Methods: The current study is a prospective controlled trial including 48 women with major depressive disorder and 48 age-matched healthy controls. Ovarian reserve tests are performed prior to treatment and after six cycles of selective serotonin reuptake inhibitor treatment in the major depressive disorder group. Serum follicle-stimulating hormone, luteinizing hormone, estradiol, and anti-Müllerian hormone levels were evaluated from blood samples, and endometrial thickness, total antral follicle count, and volume of both ovaries were assessed using transvaginal ultrasonography. Results: When the first measurements were compared, menstrual duration and menstrual bleeding increased (p = 0.007 and 0.005, respectively) and luteinizing hormone decreased (p = 0.045) in the major depressive disorder group, while follicle-stimulating hormone, estradiol, anti-Müllerian hormone, endometrial thickness, total antral follicle count, and mean ovarian volume did not differ significantly between groups (p > 0.05). When the major depressive disorder group’s first and final measurements were compared, follicle-stimulating hormone, estradiol, and endometrial thickness increased (p = 0.05, 0.0001, and 0.005, respectively), luteinizing hormone remained constant (p = 0.541), and anti-Müllerian hormone and total antral follicle count decreased (p = 0.024 and 0.042, respectively). Conclusions: In this study, we observed that the ovarian reserve test results of patients diagnosed with major depression for the first time after 6 months of SSRI treatment were significantly different from the results of the pretreatment and control groups.
Open AccessEffects of Selective Serotonin Reuptake Inhibitor Treatment on Ovarian Reserves in Patients with Depression
Background and Objectives: The goal of this study was to investigate the effect of selective serotonin reuptake inhibitor treatment on the ovarian reserves of women of reproductive age with major depressive disorder. Materials and Methods: The current study is a prospective controlled trial including 48 women with major depressive disorder and 48 age-matched healthy controls. Ovarian reserve tests are performed prior to treatment and after six cycles of selective serotonin reuptake inhibitor treatment in the major depressive disorder group. Serum follicle-stimulating hormone, luteinizing hormone, estradiol, and anti-Müllerian hormone levels were evaluated from blood samples, and endometrial thickness, total antral follicle count, and volume of both ovaries were assessed using transvaginal ultrasonography. Results: When the first measurements were compared, menstrual duration and menstrual bleeding increased (p = 0.007 and 0.005, respectively) and luteinizing hormone decreased (p = 0.045) in the major depressive disorder group, while follicle-stimulating hormone, estradiol, anti-Müllerian hormone, endometrial thickness, total antral follicle count, and mean ovarian volume did not differ significantly between groups (p > 0.05). When the major depressive disorder group’s first and final measurements were compared, follicle-stimulating hormone, estradiol, and endometrial thickness increased (p = 0.05, 0.0001, and 0.005, respectively), luteinizing hormone remained constant (p = 0.541), and anti-Müllerian hormone and total antral follicle count decreased (p = 0.024 and 0.042, respectively). Conclusions: In this study, we observed that the ovarian reserve test results of patients diagnosed with major depression for the first time after 6 months of SSRI treatment were significantly different from the results of the pretreatment and control groups.
- 31 August 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (2) , 220-226
Retrospective Analysis of Clinical and Pathological Data of Vulvar IntraepitheliaI Neoplasia Cases
Amaç: Bu çalışma kliniğimizde Vulvar İntraepitelyal Neoplazi (VIN) tanısı alan vakaların klinik ve patolojik verilerini retrospektif olarak değerlendirmek için planlandı. Gereç ve Yöntemler: Pamukkale Üniversitesinde Ocak 2016- Haziran 2020 tarihleri arasında VIN tanısı almış olan 68 hastanın dosyası retrospektif olarak değerlendirildi. Patolojik preparatlar mikroskop ile tekrar değerlendirildi. Vakalara ait sosyodemografik veriler, biyopsi ve histopatolojik veriler elde edildi. VIN vakalarına eş zamanlı olarak alınmış olan servikal Pap-smear, HPV ve servikal biyopsi sonuçları gruplandırılarak değerlendirildi. Bulgular: Çalışmaya dahil edilen 68 hastanın 48’i düşük dereceli (vLSIL), 20’si yüksek dereceli (vHSIL)’ idi. Düşük dereceli grupta ortalama yaş 48,60±16,02; gravida 2,54±1,92; parite 2,02±1,60 iken; yüksek dereceli grupta sırasıyla 44,80±14,71; 2,40±1,81; 1,70±1,49 idi. Yüksek dereceli grupta; lezyon alanı (p=0,008), Ki-67 (p=0,001), p53 (p=0,036), p16 (p=0,034) immünhistokimya boyanmaları istatistiksel olarak anlamlı şekilde daha yüksekti. HPV boyanması açısından fark yoktu (p>0,05). Eş zamanlı servikal Pap-smear, HPV-pcr ve servikal biyopsi açısından gruplar arasında istatistiksel olarak anlamlı fark yoktu (p>0,05). Sonuç: Çalışmamızda, literatüre paralel olarak servikal intraepitelyal lezyonlarda (CIN) ve yapılmış VIN çalışmalarında olduğu gibi immünohistokimyasal belirteçler yüksek dereceli grupta daha yüksek bulunmuştur. CIN ile ortak risk faktörleri içermesine rağmen, VIN için toplum tabanlı bir tarama henüz mevcut değildir. Bu nedenle şüpheli vulvar lezyonların araştırılmasında tanı için altın standart prosedür biyopsidir. VIN hastalarının tanı ve tedavileri için algoritma oluşturacak çok merkezli ileri çalışmalara ihtiyaç vardır.
- 31 August 2022
- Published by Bulent Evcevit University in Batı Karadeniz Tıp Dergisi
- Vol. 6 (2) , 220-226
Retrospective Analysis of Clinical and Pathological Data of Vulvar IntraepitheliaI Neoplasia Cases
Amaç: Bu çalışma kliniğimizde Vulvar İntraepitelyal Neoplazi (VIN) tanısı alan vakaların klinik ve patolojik verilerini retrospektif olarak değerlendirmek için planlandı. Gereç ve Yöntemler: Pamukkale Üniversitesinde Ocak 2016- Haziran 2020 tarihleri arasında VIN tanısı almış olan 68 hastanın dosyası retrospektif olarak değerlendirildi. Patolojik preparatlar mikroskop ile tekrar değerlendirildi. Vakalara ait sosyodemografik veriler, biyopsi ve histopatolojik veriler elde edildi. VIN vakalarına eş zamanlı olarak alınmış olan servikal Pap-smear, HPV ve servikal biyopsi sonuçları gruplandırılarak değerlendirildi. Bulgular: Çalışmaya dahil edilen 68 hastanın 48’i düşük dereceli (vLSIL), 20’si yüksek dereceli (vHSIL)’ idi. Düşük dereceli grupta ortalama yaş 48,60±16,02; gravida 2,54±1,92; parite 2,02±1,60 iken; yüksek dereceli grupta sırasıyla 44,80±14,71; 2,40±1,81; 1,70±1,49 idi. Yüksek dereceli grupta; lezyon alanı (p=0,008), Ki-67 (p=0,001), p53 (p=0,036), p16 (p=0,034) immünhistokimya boyanmaları istatistiksel olarak anlamlı şekilde daha yüksekti. HPV boyanması açısından fark yoktu (p>0,05). Eş zamanlı servikal Pap-smear, HPV-pcr ve servikal biyopsi açısından gruplar arasında istatistiksel olarak anlamlı fark yoktu (p>0,05). Sonuç: Çalışmamızda, literatüre paralel olarak servikal intraepitelyal lezyonlarda (CIN) ve yapılmış VIN çalışmalarında olduğu gibi immünohistokimyasal belirteçler yüksek dereceli grupta daha yüksek bulunmuştur. CIN ile ortak risk faktörleri içermesine rağmen, VIN için toplum tabanlı bir tarama henüz mevcut değildir. Bu nedenle şüpheli vulvar lezyonların araştırılmasında tanı için altın standart prosedür biyopsidir. VIN hastalarının tanı ve tedavileri için algoritma oluşturacak çok merkezli ileri çalışmalara ihtiyaç vardır.
- 4 December 2021
- Published by International Journal of Assessment Tools in Education in International Journal of Assessment Tools in Education
- Vol. 8 (4) , 764-774
The Validity and Reliability of the Turkish Version of the Attitudes to Fer-tility and Childbearing Scale (AFCS)
This study, a descriptive and methodological type of research, was conducted to evaluate the validity and reliability of the Turkish adaptation of the Attitudes to Fertility and Childbearing Scale (AFCS), developed by Söderberg et al. (2015). The sample of this study consisted of 224 women who had not given birth yet and who were between the ages of 20-30. The scale is a Likert-type measuring instrument consisting of 21 items, in three dimensions. Internal consistency analyses were conducted to determine its reliability. After confirming the linguistic validity, expert opinions were obtained for the content validity. Furthermore, the Item Content Validity Index (I-CVI) and the Scale Content Validity Index (S-CVI) were used to assess its content validity. The construct validity was performed using confirmatory factor analysis. As a result of the confirmatory factor analysis carried out for the construct validity, a three-factor structure of the scale was found to have a good level of model fitness indices (RMSEA=.067, SRMR=.075, CFI=.96). As a result of the scale reliability analysis, the internal consistency coefficient was found to be .82 for the total scale and internal consistency reliability coefficients of the sub-scales were found to be .93 for the "importance of fertility for the future" sub-scale, .87 for the "childbearing as a hindrance at present" sub-scale, and .81 for the "social identity" sub-scale. AFCS is a valid and reliable measurement tool that can be used to measure the fertility and childbearing attitudes of women in a fertile age.
- 4 December 2021
- Published by International Journal of Assessment Tools in Education in International Journal of Assessment Tools in Education
- Vol. 8 (4) , 764-774
The Validity and Reliability of the Turkish Version of the Attitudes to Fer-tility and Childbearing Scale (AFCS)
This study, a descriptive and methodological type of research, was conducted to evaluate the validity and reliability of the Turkish adaptation of the Attitudes to Fertility and Childbearing Scale (AFCS), developed by Söderberg et al. (2015). The sample of this study consisted of 224 women who had not given birth yet and who were between the ages of 20-30. The scale is a Likert-type measuring instrument consisting of 21 items, in three dimensions. Internal consistency analyses were conducted to determine its reliability. After confirming the linguistic validity, expert opinions were obtained for the content validity. Furthermore, the Item Content Validity Index (I-CVI) and the Scale Content Validity Index (S-CVI) were used to assess its content validity. The construct validity was performed using confirmatory factor analysis. As a result of the confirmatory factor analysis carried out for the construct validity, a three-factor structure of the scale was found to have a good level of model fitness indices (RMSEA=.067, SRMR=.075, CFI=.96). As a result of the scale reliability analysis, the internal consistency coefficient was found to be .82 for the total scale and internal consistency reliability coefficients of the sub-scales were found to be .93 for the "importance of fertility for the future" sub-scale, .87 for the "childbearing as a hindrance at present" sub-scale, and .81 for the "social identity" sub-scale. AFCS is a valid and reliable measurement tool that can be used to measure the fertility and childbearing attitudes of women in a fertile age.
- Open Access
- 1 June 2021
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 5 (6) , 611-614
The association of vitamin D with semen quality and fertility hormones in idiopathic recurrent pregnancy loss without the female factor
Background/Aim: There is a lack of data about male contribution to idiopathic recurrent pregnancy loss (IRPL). The study aimed to investigate the factors associated with males, including Vitamin D, semen parameters, fertility hormones, and some demographical features in IRPL. Methods: In this cross-sectional study, the data of 41 men whose partners were diagnosed with recurrent pregnancy loss between February 2014 to February 2015 were collected. Female partners were examined fully, including thrombophilia factors, and no cause was detected. The karyotypes of both partners were normal. Men’s 25-hydroxy-vitamin D (25-OH-VD) levels, semen parameters (ejaculate volume, total sperm count per ejaculate, sperm concentration, sperm progressive motility, and sperm morphology), and fertility hormones (follicle-stimulating hormone, luteinizing hormone, total testosterone, estradiol, and prolactin) were assessed. Results: Mean 25-OH-VD was lower (18.4 (9.6) ng/ml) than the normal range. We found that testosterone was significantly lower in the group with 25-OH-VD ≤19 ng/dl when compared to the group with 25-OH-VD ≥20 ng/ml. There is a positive correlation between 25-OH-VD and testosterone levels. Although it was not statistically significant, there was a tendency for decreased sperm morphology. Conclusion: Serum testosterone levels of men whose partners were diagnosed with IRPL decreased with lower 25-OH-VD levels. In addition to standard female factors, male factors should also be taken into consideration when evaluating the risk of IRPL. '+st+' Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–11. doi: 10.1016/j.fertnstert.2012.06.048. Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes. 2009;16:446–50. doi: 10.1097/MED.0b013e3283327fc5. Kiwi R. Recurrent pregnancy loss: evaluation and discussion of the causes and their management. Cleve Clin J Med. 2006;73:913–21. doi: 10.3949/ccjm.73.10.913. El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet PE. Recurrent pregnancy loss: current perspectives. Int J Womens Health. 2017;9:331–45. doi: 10.2147/IJWH.S100817. Puscheck EE, Jeyendran RS. The impact of male factor on recurrent pregnancy loss. Curr Opin Obstet Gynecol. 2007;19:222–8. doi: 10.1097/GCO.0b013e32813e3ff0. Ruixue W, Hongli Z, Zhihong Z, Rulin D, Dongfeng G, Ruizhi L. The impact of semen quality, occupational exposure to environmental factors and lifestyle on recurrent pregnancy loss. J Assist Reprod Genet. 2013;30:1513–8. doi: 10.1007/s10815-013-0091-1. Dickey R, Ramasamy R. Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure. Reprod Syst Sex Disord. 2015;4(3):1000e122. doi: 10.4172/2161-038X.1000e122. Cao X, Cui Y, Zhang X, Lou J, Zhou J, Wei R. The correlation of sperm morphology with unexplained recurrent spontaneous abortion: A systematic review and meta-analysis. Oncotarget. 2017;8:55646–56. doi: 10.18632/oncotarget.17233. Talebi AR, Vahidi S, Aflatoonian A, Ghasemi N, Ghasemzadeh J, Firoozabadi RD, et al. Cytochemical evaluation of sperm chromatin and DNA integrity in couples with unexplained recurrent spontaneous abortions. Andrologia. 2012;44:462–70. doi: 10.1111/j.1439-0272.2011.01206.x. Absalan F, Ghannadi A, Kazerooni M, Parifar R, Jamalzadeh F, Amiri S. Value of sperm chromatin dispersion test in couples with unexplained recurrent abortion. J Assist Reprod Genet. 2012;29(1):11–4. doi: 10.1007/s10815-011-9647-0. Esteves SC, Zini A, Coward RM, Evenson DP, Gosálvez J, Lewis SEM, et al. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia. 2021;53:13874. doi: 10.1111/and.13874. Jayasena CN, Radia UK, Figueiredo M, Revill LF, Dimakopoulou A, Osagie M, et al. Reduced Testicular Steroidogenesis and Increased Semen Oxidative Stress in Male Partners as Novel Markers of Recurrent Miscarriage. Clin Chem. 2019;65:16–9. doi: 10.1373/clinchem.2018.289348. Corbett ST, Hill O, Nangia AK. Vitamin D receptor found in human sperm. Urology. 2006;68(6):1345–9. doi: 10.1016/j.urology.2006.09.011. Aquila S, Guido C, Middea E, Perrotta I, Bruno R, Pellegrino M, et al. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1.25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol. 2009;7:140. doi: 10.1186/1477-7827-7-140. Blomberg Jensen M, Nielsen JE, Jørgensen A, Rajpert-De Meyts E, Kristensen DM, Jørgensen N, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25(5):1303–11. doi: 10.1093/humrep/deq024. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf). 2010;73:243–8. doi: 10.1111/j.1365-2265.2009.03777.x. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol. 1996;105(1):7–15. doi: 10.1007/BF01450873. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Andò S. Human sperm anatomy: ultrastructural localization of 1alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete. J Anat. 2008;213(5):555–64. doi: 10.1111/j.1469-7580.2008.00975.x. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141:1317–24. doi: 10.1210/endo.141.4.7403. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen...
- 1 June 2021
- Published by SelSistem in Journal of Surgery and Medicine
- Vol. 5 (6) , 611-614
Open AccessThe association of vitamin D with semen quality and fertility hormones in idiopathic recurrent pregnancy loss without the female factor
Background/Aim: There is a lack of data about male contribution to idiopathic recurrent pregnancy loss (IRPL). The study aimed to investigate the factors associated with males, including Vitamin D, semen parameters, fertility hormones, and some demographical features in IRPL. Methods: In this cross-sectional study, the data of 41 men whose partners were diagnosed with recurrent pregnancy loss between February 2014 to February 2015 were collected. Female partners were examined fully, including thrombophilia factors, and no cause was detected. The karyotypes of both partners were normal. Men’s 25-hydroxy-vitamin D (25-OH-VD) levels, semen parameters (ejaculate volume, total sperm count per ejaculate, sperm concentration, sperm progressive motility, and sperm morphology), and fertility hormones (follicle-stimulating hormone, luteinizing hormone, total testosterone, estradiol, and prolactin) were assessed. Results: Mean 25-OH-VD was lower (18.4 (9.6) ng/ml) than the normal range. We found that testosterone was significantly lower in the group with 25-OH-VD ≤19 ng/dl when compared to the group with 25-OH-VD ≥20 ng/ml. There is a positive correlation between 25-OH-VD and testosterone levels. Although it was not statistically significant, there was a tendency for decreased sperm morphology. Conclusion: Serum testosterone levels of men whose partners were diagnosed with IRPL decreased with lower 25-OH-VD levels. In addition to standard female factors, male factors should also be taken into consideration when evaluating the risk of IRPL. '+st+' Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103–11. doi: 10.1016/j.fertnstert.2012.06.048. Allison JL, Schust DJ. Recurrent first trimester pregnancy loss: revised definitions and novel causes. Curr Opin Endocrinol Diabetes Obes. 2009;16:446–50. doi: 10.1097/MED.0b013e3283327fc5. Kiwi R. Recurrent pregnancy loss: evaluation and discussion of the causes and their management. Cleve Clin J Med. 2006;73:913–21. doi: 10.3949/ccjm.73.10.913. El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet PE. Recurrent pregnancy loss: current perspectives. Int J Womens Health. 2017;9:331–45. doi: 10.2147/IJWH.S100817. Puscheck EE, Jeyendran RS. The impact of male factor on recurrent pregnancy loss. Curr Opin Obstet Gynecol. 2007;19:222–8. doi: 10.1097/GCO.0b013e32813e3ff0. Ruixue W, Hongli Z, Zhihong Z, Rulin D, Dongfeng G, Ruizhi L. The impact of semen quality, occupational exposure to environmental factors and lifestyle on recurrent pregnancy loss. J Assist Reprod Genet. 2013;30:1513–8. doi: 10.1007/s10815-013-0091-1. Dickey R, Ramasamy R. Role of Male Factor Testing in Recurrent Pregnancy Loss or In Vitro Fertilization Failure. Reprod Syst Sex Disord. 2015;4(3):1000e122. doi: 10.4172/2161-038X.1000e122. Cao X, Cui Y, Zhang X, Lou J, Zhou J, Wei R. The correlation of sperm morphology with unexplained recurrent spontaneous abortion: A systematic review and meta-analysis. Oncotarget. 2017;8:55646–56. doi: 10.18632/oncotarget.17233. Talebi AR, Vahidi S, Aflatoonian A, Ghasemi N, Ghasemzadeh J, Firoozabadi RD, et al. Cytochemical evaluation of sperm chromatin and DNA integrity in couples with unexplained recurrent spontaneous abortions. Andrologia. 2012;44:462–70. doi: 10.1111/j.1439-0272.2011.01206.x. Absalan F, Ghannadi A, Kazerooni M, Parifar R, Jamalzadeh F, Amiri S. Value of sperm chromatin dispersion test in couples with unexplained recurrent abortion. J Assist Reprod Genet. 2012;29(1):11–4. doi: 10.1007/s10815-011-9647-0. Esteves SC, Zini A, Coward RM, Evenson DP, Gosálvez J, Lewis SEM, et al. Sperm DNA fragmentation testing: Summary evidence and clinical practice recommendations. Andrologia. 2021;53:13874. doi: 10.1111/and.13874. Jayasena CN, Radia UK, Figueiredo M, Revill LF, Dimakopoulou A, Osagie M, et al. Reduced Testicular Steroidogenesis and Increased Semen Oxidative Stress in Male Partners as Novel Markers of Recurrent Miscarriage. Clin Chem. 2019;65:16–9. doi: 10.1373/clinchem.2018.289348. Corbett ST, Hill O, Nangia AK. Vitamin D receptor found in human sperm. Urology. 2006;68(6):1345–9. doi: 10.1016/j.urology.2006.09.011. Aquila S, Guido C, Middea E, Perrotta I, Bruno R, Pellegrino M, et al. Human male gamete endocrinology: 1alpha, 25-dihydroxyvitamin D3 (1.25(OH)2D3) regulates different aspects of human sperm biology and metabolism. Reprod Biol Endocrinol. 2009;7:140. doi: 10.1186/1477-7827-7-140. Blomberg Jensen M, Nielsen JE, Jørgensen A, Rajpert-De Meyts E, Kristensen DM, Jørgensen N, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25(5):1303–11. doi: 10.1093/humrep/deq024. Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol (Oxf). 2010;73:243–8. doi: 10.1111/j.1365-2265.2009.03777.x. Johnson JA, Grande JP, Roche PC, Kumar R. Immunohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol. 1996;105(1):7–15. doi: 10.1007/BF01450873. Aquila S, Guido C, Perrotta I, Tripepi S, Nastro A, Andò S. Human sperm anatomy: ultrastructural localization of 1alpha,25-dihydroxyvitamin D receptor and its possible role in the human male gamete. J Anat. 2008;213(5):555–64. doi: 10.1111/j.1469-7580.2008.00975.x. Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141:1317–24. doi: 10.1210/endo.141.4.7403. Cooper TG, Noonan E, von Eckardstein S, Auger J, Baker HW, Behre HM, et al. World Health Organization reference values for human semen...
- Open Access
- 1 May 2020
- Published by Pamukkale Tip Dergisi in Pamukkale Medical Journal
Multidisipliner çalışmalarda dikkat edilmesi gereken noktalar
İnfertil kadınlarda Chlamydia trachomatis seroprevalansı ve güncel durumun irdelenmesi (Pam Med J 2020;13:149-154)
- 1 May 2020
- Published by Pamukkale Tip Dergisi in Pamukkale Medical Journal
Open AccessMultidisipliner çalışmalarda dikkat edilmesi gereken noktalar
İnfertil kadınlarda Chlamydia trachomatis seroprevalansı ve güncel durumun irdelenmesi (Pam Med J 2020;13:149-154)